
Topotecan
Form: Oral capsules, Injection
Strength: Capsule: 1 mg, 2.5 mg; Injection:4 mg/4 mL
Reference Brands: Hycamtin® (EU & US)
Category: Oncology Cancer Care
Topotecan, marketed under the brand Hycamtin®, is a vital chemotherapy agent used to treat cancers such as ovarian, small cell lung cancer, and cervical cancer. Available in IV injection and oral capsule forms, with strengths like 4 mg/4 mL (injection) and 1 mg (oral capsules), Topotecan works by inhibiting topoisomerase I, preventing cancer cells from replicating. Sourced by B2B pharmaceutical suppliers, Topotecan ensures GMP-compliant manufacturing and a reliable supply to oncology centers in the US and EU, providing effective treatment for aggressive cancers with competitive pricing.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Atezolizumab
Strength: 1200 mg/20 mL
Form: Intravenous infusion
Reference Brands: Tecentriq® (EU & US)
View DetailsDurvalumab
Strength: 120 mg/4 mL, 500 mg/10 mL
Form: Injection
Reference Brands: Imfinzi® (US & EU)
View DetailsSunitinib
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg
Form: Tablet
Reference Brands: Sutent® (EU & US)
View DetailsIfosfamide
Strength: 1 g/vial,2 g/vial, 3 g/vial
Form: Injection
Reference Brands: Ifex® (US), Holoxan® (EU)
View Details